Elevance Health Inc. Stock Climbs 7.6%, Outperforms Peers

Dow Jones
07/02

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Elevance Health Inc. advanced 7.6% to $416.19 on what proved to be an all-around poor trading session for the stock market, with the Dow Jones Industrial Average remaining mostly unchanged at 52,305.24 and the S&P 500 Index falling 0.2% to 7,483.23.

The stock's rise snapped a two-day losing streak.

Elevance Health Inc. closed 2.5% short of its 52-week high of $426.98, which the company reached on June 10th.

The stock outperformed some of its peers, as UnitedHealth Group Inc. rose 2.6% to $426.54, Cigna Group rose 0.5% to $277.07, and Humana Inc. rose 3.07% to $409.42.

Trading volume totaled 2.1 million, compared to the 50-day average of 1.8 million.

Data source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

July 01, 2026 16:34 ET (20:34 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10